The Dutch pharmaceutical industry has been ahead of the curve with respect to self-imposed transparency requirements. Although there may be some disagreement about how “cool” such disclosure requirements are, there can be no dispute that the pharmaceutical industry prefers an industry-generated solution over a governmental-imposed transparency scheme. There also can be no dispute that the Dutch pharmaceutical industry has proceeded with self-regulatory transparency measures far more quickly than its counterparts around the world.
Please click here to read the full article.